Zheng Ke, Feng Guijuan, Zhang Jinlong, Xing Jing, Huang Dan, Lian Min, Zhang Wei, Wu Wenli, Hu Yingzi, Lu Xiaohui, Feng Xingmei
Department of Stomatology, Wuxi No. 2 People's Hospital, Wuxi, China.
Department of Stomatology, Affiliated Hospital of Nantong University, Nantong, China.
Int J Neurosci. 2021 Jul;131(7):625-633. doi: 10.1080/00207454.2020.1744592. Epub 2020 Apr 5.
AIM/PURPOSE: Dental pulp stem cells (DPSCs) were widely used as seed cells in the field of tissue engineering and regenerative medicine, including spinal cord injury (SCI) repair and other neuronal degenerative diseases, due to their easy isolation, multiple differentiation potential, low immunogenicity and low rates of rejection during transplantation. Various studies have shown that bFGF can enhance peripheral nerve regeneration after injury, and phospho-ERK (p-ERK) activation as a major mediator may be involved in this process. Previous studies also have proved that a suitable biomaterial scaffold can carry and transport the therapeutic cells effectively to the recipient area. It has showed in our earlier experiments that 3D porous chitosan scaffolds exhibited a suitable circumstance for survival and neural differentiation of DPSCs . The purpose of the study was to evaluate the influence of chitosan scaffolds and bFGF on differentiation of DPSCs. MATERIALS AND METHODS: In current study, DPSCs were cultured in chitosan scaffolds and treated with neural differentiation medium for 7 days. The neural genes and protein markers were analyzed by western blot and immunofluorescence. Meanwhile, the relevant signaling pathway involved in this process was also tested. RESULTS: Our study revealed that the viability of DPSCs was not influenced by co-culture with the chitosan scaffolds as well as bFGF. Compared with the control and DPSC/chitosan-scaffold groups, the levels of GFAP, S100β and β-tubulin III significantly increased in the DPSC/chitosan-scaffold+bFGF group. CONCLUSION: Chitosan scaffolds were non-cytotoxic to the survival of DPSCs, and chitosan scaffolds combined with bFGF facilitated the neural differentiation of DPSCs. The transplantation of DPSCs/chitosan-scaffold+bFGF might be a secure and effective method of treating SCI and other neuronal diseases.
目的:牙髓干细胞(DPSCs)因其易于分离、具有多向分化潜能、免疫原性低且移植排斥率低,在组织工程和再生医学领域被广泛用作种子细胞,包括脊髓损伤(SCI)修复及其他神经退行性疾病。多项研究表明,碱性成纤维细胞生长因子(bFGF)可促进损伤后周围神经再生,而磷酸化细胞外信号调节激酶(p-ERK)激活作为主要介导因素可能参与此过程。先前研究还证明,合适的生物材料支架可有效携带和运输治疗性细胞至受体区域。我们早期实验表明,三维多孔壳聚糖支架为DPSCs的存活和神经分化提供了适宜环境。本研究目的是评估壳聚糖支架和bFGF对DPSCs分化的影响。 材料与方法:在本研究中,DPSCs在壳聚糖支架中培养,并用神经分化培养基处理7天。通过蛋白质免疫印迹法和免疫荧光分析神经基因和蛋白质标志物。同时,也检测了该过程中涉及的相关信号通路。 结果:我们的研究表明,与壳聚糖支架及bFGF共培养对DPSCs的活力无影响。与对照组和DPSC/壳聚糖支架组相比,DPSC/壳聚糖支架+bFGF组中胶质纤维酸性蛋白(GFAP)、S100β和β-微管蛋白III的水平显著升高。 结论:壳聚糖支架对DPSCs的存活无细胞毒性,壳聚糖支架联合bFGF促进了DPSCs的神经分化。DPSCs/壳聚糖支架+bFGF移植可能是治疗SCI和其他神经疾病的一种安全有效的方法。
Cell Mol Neurobiol. 2014-8
J Biomater Appl. 2015-8
Mater Sci Eng C Mater Biol Appl. 2017-11-1
In Vitro Cell Dev Biol Anim. 2025-9-8
Front Bioeng Biotechnol. 2025-2-25
Stem Cell Res Ther. 2025-3-7
Polymers (Basel). 2024-9-14
Pharmaceuticals (Basel). 2024-6-7
Biomedicines. 2024-3-19